[The expression of TRAIL, TRAIL-R (DR4, DcR1) and Fas-L in patients with ovarian cancer]
- PMID: 15931863
[The expression of TRAIL, TRAIL-R (DR4, DcR1) and Fas-L in patients with ovarian cancer]
Abstract
Objective: To investigate the apoptosis induced by TRAIL, TRAIL-R and Fas-L in patients
Methods: The expression of TRAIL, TRAIL-R (DR4,DcR1) and Fas-L in ovarian cancer was detected with immunohistochemistry.
Results: The levels of DR4 and DcR1 expression in ovarian carcinoma with ovarian carcinoma were lower than that of normal tissues. The positive rate of DR4 in well-differentiated ovarian carcinoma was significantly higher than that in poorly differentiated ovarian carcinoma (92.31% vs 54.55%, P < 0.05). The expression of TRAIL was significantly correlated with that of Fas-L (r = 0.777).
Conclusion: The expressions of DR4 and DcR1 are lower than that of normal tissues, and the expression of DR4 might be a prognostic factor in ovarian cancer.
Similar articles
-
Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8585-91. doi: 10.1158/1078-0432.CCR-05-1276. Clin Cancer Res. 2005. PMID: 16361541
-
Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.Clin Cancer Res. 2003 Aug 15;9(9):3397-405. Clin Cancer Res. 2003. PMID: 12960128
-
The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer.Gynecol Oncol. 2010 Mar;116(3):549-55. doi: 10.1016/j.ygyno.2009.09.014. Epub 2009 Dec 3. Gynecol Oncol. 2010. PMID: 19959214
-
Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts.Haematologica. 2006 Mar;91(3):386-9. Haematologica. 2006. PMID: 16531263
-
CD95L/FasL and TRAIL in tumour surveillance and cancer therapy.Cancer Treat Res. 2006;130:141-65. doi: 10.1007/0-387-26283-0_7. Cancer Treat Res. 2006. PMID: 16610707 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous